Ad is loading...
RLFTF
Price
$6.94
Change
-$0.52 (-6.97%)
Updated
Nov 15 closing price
TRRI
Price
$0.12
Change
-$0.00 (-0.00%)
Updated
Oct 31 closing price
Ad is loading...

RLFTF vs TRRI

Header iconRLFTF vs TRRI Comparison
Open Charts RLFTF vs TRRIBanner chart's image
RELIEF THERAPEUTICS HLDG AG
Price$6.94
Change-$0.52 (-6.97%)
Volume$1.73K
CapitalizationN/A
Trinity Resources
Price$0.12
Change-$0.00 (-0.00%)
Volume$6.07K
CapitalizationN/A
RLFTF vs TRRI Comparison Chart
Loading...
View a ticker or compare two or three
VS
RLFTF vs. TRRI commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLFTF is a Buy and TRRI is a Buy.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (RLFTF: $6.94 vs. TRRI: $0.12)
Brand notoriety: RLFTF and TRRI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLFTF: 38% vs. TRRI: 254%
Market capitalization -- RLFTF: $85.88M vs. TRRI: $182.14K
RLFTF [@Biotechnology] is valued at $85.88M. TRRI’s [@Biotechnology] market capitalization is $182.14K. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLFTF’s FA Score shows that 1 FA rating(s) are green whileTRRI’s FA Score has 1 green FA rating(s).

  • RLFTF’s FA Score: 1 green, 4 red.
  • TRRI’s FA Score: 1 green, 4 red.
According to our system of comparison, both RLFTF and TRRI are a bad buy in the long-term.

Price Growth

RLFTF (@Biotechnology) experienced а +7.26% price change this week, while TRRI (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
RLFTF($85.9M) has a higher market cap than TRRI($182K). RLFTF YTD gains are higher at: 212.613 vs. TRRI (-39.500).
RLFTFTRRIRLFTF / TRRI
Capitalization85.9M182K47,198%
EBITDA-48.16MN/A-
Gain YTD212.613-39.500-538%
P/E RatioN/AN/A-
Revenue8.59MN/A-
Total Cash10.7MN/A-
Total Debt2.42MN/A-
FUNDAMENTALS RATINGS
TRRI: Fundamental Ratings
TRRI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
USM61.54-0.08
-0.13%
United States Cellular Corp
MRO28.59-0.15
-0.52%
Marathon Oil Corp
CLWT1.44-0.01
-0.69%
Euro Tech Holdings Company Limited
VSTM3.99-0.14
-3.39%
Verastem
CCO1.57-0.07
-4.27%
Clear Channel Outdoor Holdings

RLFTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLFTF has been loosely correlated with RLFTY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RLFTF jumps, then RLFTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLFTF
1D Price
Change %
RLFTF100%
-6.97%
RLFTY - RLFTF
44%
Loosely correlated
-9.74%
ORKA - RLFTF
30%
Poorly correlated
+0.17%
TRRI - RLFTF
22%
Poorly correlated
N/A
DRUG - RLFTF
21%
Poorly correlated
-7.78%
PCVX - RLFTF
20%
Poorly correlated
-6.31%
More

TRRI and

Correlation & Price change

A.I.dvisor tells us that TRRI and TNFA have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TRRI and TNFA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRRI
1D Price
Change %
TRRI100%
N/A
TNFA - TRRI
27%
Poorly correlated
-2.75%
RLFTF - TRRI
24%
Poorly correlated
-6.97%
RLFTY - TRRI
22%
Poorly correlated
-9.74%
PRLD - TRRI
22%
Poorly correlated
+0.97%
SRBCF - TRRI
12%
Poorly correlated
-7.02%
More